Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth Dickstein

Showing results (251-260 of 372) with videos related to

Pageof 38
Sort By:
European Journal of Heart Failure|March 11, 2015
International REgistry to assess medical Practice with lOngitudinal obseRvation for Treatment of Heart Failure (REPORT-HF): rationale for and design of a global registryGerasimos Filippatos, Sadiya Sana Khan, Andrew P Ambrosy, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|February 1, 2020
Higher doses of loop diuretics limit uptitration of angiotensin-converting enzyme inhibitors in patients with heart failure and reduced ejection fractionJozine M Ter Maaten, Pieter Martens, Kevin Damman, et al.
European Journal of Heart Failure|April 30, 2016
A systems BIOlogy Study to TAilored Treatment in Chronic Heart Failure: rationale, design, and baseline characteristics of BIOSTAT-CHFAdriaan A Voors, Stefan D Anker, John G Cleland, et al.
European Journal of Heart Failure|January 4, 2023
Biomarker signature and pathophysiological pathways in patients with chronic heart failure and metabolic syndromeCamilla C S van der Hoef, Eva M Boorsma, Johanna E Emmens, et al.
European Journal of Heart Failure|March 8, 2019
Bio-adrenomedullin as a marker of congestion in patients with new-onset and worsening heart failureJozine M Ter Maaten, Daan Kremer, Biniyam G Demissei, et al.
Journal of the American College of Cardiology|January 10, 2019
Differential Impact of Heart Failure With Reduced Ejection Fraction on Men and WomenPooja Dewan, Rasmus Rørth, Pardeep S Jhund, et al.
Journal of the American College of Cardiology|October 21, 2017
The PCSK9-LDL Receptor Axis and Outcomes in Heart Failure: BIOSTAT-CHF SubanalysisAntoni Bayes-Genis, Julio Núñez, Faiez Zannad, et al.
Plos One|March 20, 2012
The homeostatic chemokine CCL21 predicts mortality and may play a pathogenic role in heart failureArne Yndestad, Alexandra Vanessa Finsen, Thor Ueland, et al.
Circulation. Heart Failure|November 17, 2017
Contemporary Characteristics and Outcomes in Chagasic Heart Failure Compared With Other Nonischemic and Ischemic CardiomyopathyLi Shen, Felix Ramires, Felipe Martinez, et al.
European Journal of Heart Failure|December 19, 2019
Relationship between heart rate and outcomes in patients in sinus rhythm or atrial fibrillation with heart failure and reduced ejection fractionKieran F Docherty, Li Shen, Davide Castagno, et al.
Pageof 38

Showing results (251-260 of 372) with videos related to

Sort By:
Pageof 38
European Journal of Heart Failure|March 11, 2015
International REgistry to assess medical Practice with lOngitudinal obseRvation for Treatment of Heart Failure (REPORT-HF): rationale for and design of a global registryGerasimos Filippatos, Sadiya Sana Khan, Andrew P Ambrosy, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|February 1, 2020
Higher doses of loop diuretics limit uptitration of angiotensin-converting enzyme inhibitors in patients with heart failure and reduced ejection fractionJozine M Ter Maaten, Pieter Martens, Kevin Damman, et al.
European Journal of Heart Failure|April 30, 2016
A systems BIOlogy Study to TAilored Treatment in Chronic Heart Failure: rationale, design, and baseline characteristics of BIOSTAT-CHFAdriaan A Voors, Stefan D Anker, John G Cleland, et al.
European Journal of Heart Failure|January 4, 2023
Biomarker signature and pathophysiological pathways in patients with chronic heart failure and metabolic syndromeCamilla C S van der Hoef, Eva M Boorsma, Johanna E Emmens, et al.
European Journal of Heart Failure|March 8, 2019
Bio-adrenomedullin as a marker of congestion in patients with new-onset and worsening heart failureJozine M Ter Maaten, Daan Kremer, Biniyam G Demissei, et al.
Journal of the American College of Cardiology|January 10, 2019
Differential Impact of Heart Failure With Reduced Ejection Fraction on Men and WomenPooja Dewan, Rasmus Rørth, Pardeep S Jhund, et al.
Journal of the American College of Cardiology|October 21, 2017
The PCSK9-LDL Receptor Axis and Outcomes in Heart Failure: BIOSTAT-CHF SubanalysisAntoni Bayes-Genis, Julio Núñez, Faiez Zannad, et al.
Plos One|March 20, 2012
The homeostatic chemokine CCL21 predicts mortality and may play a pathogenic role in heart failureArne Yndestad, Alexandra Vanessa Finsen, Thor Ueland, et al.
Circulation. Heart Failure|November 17, 2017
Contemporary Characteristics and Outcomes in Chagasic Heart Failure Compared With Other Nonischemic and Ischemic CardiomyopathyLi Shen, Felix Ramires, Felipe Martinez, et al.
European Journal of Heart Failure|December 19, 2019
Relationship between heart rate and outcomes in patients in sinus rhythm or atrial fibrillation with heart failure and reduced ejection fractionKieran F Docherty, Li Shen, Davide Castagno, et al.
Pageof 38